Long-term follow up of a randomized, controlled trial on prophylactic sclerotherapy of small oesophageal varices in liver cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 3, 1999, Pages 225-230

  Strauss, Edna ^a,b   De Fátima, Maria ^a   Ribeiro, Gomes S ^a   Albano, Armando ^a   Honain, Nadim Z ^a   Maffei Jr , Romeu A ^a   Caly, Wanda R ^a  

^a HOSPITAL HELIÓPOLIS   (Brazil)

^b NONE   (Brazil)

Author keywords

Cirrhosis; Comparative trial; First upper gastrointestinal bleeding; Oesophageal varices; Portal hypertension; Prophylaxis; Sclerotherapy; Varices; Varices grade I

Indexed keywords

MONOETHANOLAMINE OLEATE; SCLEROSING AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPHAGIA; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS ULCER; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; MALE; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032893311     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01799.x     Document Type: Article

References (48)

1. 1 Garceau AJ, Chalmers TC, Boston Inter-hospital Liver Group. The natural history of cirrhosis: I. Survival with esophageal varices. N. Engl. J. Med. 1963; 268: 469-73.
2. 2 Fleig WE, Stange EF. Esophageal varices: Current therapy in 1989. Endoscopy 1989; 21: 89-96.
3. 3 Idezuki Y. Present status of sclerotherapy and surgical treatment of esophageal varices in Japan. World J. Surg. 1992; 16: 1193-200.
4. 4 The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicemer study. N. Engl. J. Med. 1988; 319: 983-9.
5. 5 Strauss E, Pinheiro AJ, Santos WR. História natural da hemorragia digestiva alta na cirrose hepática. GED 1984; 3: 113-20.
6. 6 Conn H, Resnick RH, Grace ND et al. Distal splenorenal shunt vs porta-systemic shunt: Current status of a controlled trial. Hepatology 1981; 1: 151-60.
7. 7 Orloff MJ, Bell RH, Hyde PV, Skivolocki WP. Long-term results of emergency portocaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis. Ann. Surg. 1980; 192: 325-39.
8. 8 Rueff B, Degos F, Degos JD et al. A controlled study of therapeutic portocaval shunt in alcoholic cirrhosis. Lancet 1976; i: 655-9.
9. 9 Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study. N. Engl. J. Med. 1981; 305: 1371-4.
10. 10 Lebrec D, Poynard T, Bernuau J et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A final report. Hepatology 1984; 4: 355-8.
11. 11 Colombo M, De Franchis R, Tommasini M, Sangiovanni A, Diognardi N. Beta-blockade prevents recurrent gastrointestinal bleeding in well compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial. Hepatology 1989; 9: 433-8.
12. 12 Burroughs AK, Jenkins WJ, Sherlock S et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N. Engl. J. Med. 1983; 309: 1539-42.
13. 13 Villeneuve JP, Pomier Layrargues GI, Infant Rivard C et al. Propranolol for the prevention of recurrent variceal haemorrhage: A controlled trial. Hepatology 1986; 6: 1239-43.
14. 14 The Italian Multicentric Project for Propranolol in the Prevention of Bleeding. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: A multicenter, randomized clinical trial. Hepatology 1988; 8: 1-5.
15. 15 Strauss E, Sá MFG, Monteiro JP, Honain NZ, Caly WR. Propranolol for the prevention of the first upper gastrointestinal bleeding in hepatic cirrhosis: A randomized controlled trial. Acta Hepatológica 1991; 1: 7-12.
16. 16 Ideo G, Bellati G, Fesce E, Grimold D. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: A prospective randomized trial. Hepatology 1988; 8: 6-9.
17. 17 Conn HO, Grace ND, Bosch J et al. Propranolol for the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. Hepatology 1991; 13: 902-12.
18. 18 Lebrec D, Poynard T, Capron JP et al. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis: A randomized trial. J. Hepatol. 1988; 7: 118-25.
19. 19 Pascal JP, Cales P, Multicenter Study Group. Propranolol in the prevention of first upper GI tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N. Engl. J. Med. 1987; 317: 856-61.
20. 20 Hayes PC, Davis JM, Lewis JA, Bouchier IA. Metaanalysis of the value of propranolol in prevention of variceal bleeding. Lancet 1990; 336: 153-6.
21. 21 Koch H, Henning H, Grimm H, Soehendra N. Prophylactic sclerosing of esophageal varices: Results of a prospective controlled study. Endoscopy 1986; 18: 40-3.
22. 22 Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices. A prospective controlled randomized trial. Endoscopy 1982; 14: 4-5.
23. 23 Piai G, Cipolletta L, Claar M et al. Prophylactic sclerotherapy of high risk esophageal varices: Results of a multicentric prospective controlled trial. Hepatology 1988; 8: 1495-500.
24. 24 Witzel L, Wolbergs H, Merki H. Prophylactic endoscopic sclerotherapy of esophageal varices. A prospective controlled study. Lancet 1985; i: 773-5.
25. 25 Beppu K, Inokuchi K, Koyanagi N et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest. Endosc. 1981; 27: 213-18.
26. 26 Kobe E, Zippirich B, Schentke KV, Nilius R. Prophylactic endoscopic sclerotherapy of esophageal varices. A prospective randomized trial. Endoscopy 1990; 22: 245-8.
27. 27 Potzi R, Bauer P, Reichel W et al. Prophylactic endoscopy sclerotherapy of esophageal varices in liver cirrhosis: A multicentre prospective controlled randomized trial in Vienna. Gut 1989; 30: 873-9.
28. 28 Sauerbruch T, Wotzka R, Kopke W et al. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N. Engl. J. Med. 1988; 319: 8-15.
29. 29 Heaton ND, Howard ER. Complications and limitations of sclerotherapy in portal hypertension. Gut 1993; 34: 3-10.
30. 30 Russo A, Giannone G, Magnano A, Passanisi G, Giannone N. Endoscopic esophageal sclerotherapy: Long-term results of the elective procedure. Dig. Dis. 1992; 10 (Suppl. 1): 65-73.
31. 31 Westaby D, Williams R. Status of sclerotherapy of variceal bleeding in 1990. Am. J. Surg. 1990; 160: 32-6.
32. 32 Strauss E, Sá MFG, Albano A, Lacet CMC, Leite MO, Maffei Jr RA. A randomized controlled trial for the prevention of the first upper gastrointestinal bleeding due to portal hypertension in cirrhosis: Sclerotherapy or propranolol versus control groups. Hepatology 1988; 8: 1395 (Abstract).
33. 33 Russo A, Giannone G, Magnano A, Passanisi G, Longo C. Prophylactic sclerotherapy in nonalcoholic liver cirrhosis: Preliminary results of a prospective controlled randomized trial. World J. Surg. 1989; 13: 149-53.
34. 34 Santangelo WC, Dueno MI, Estes BL, Krejs GJ. Prophylactic sclerotherapy of large esophageal varices. N. Engl. J. Med. 1988; 318: 814-18.
35. 35 Gregory J, The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N. Engl. J. Med. 1991; 324: 1779-84.
36. 36 Andreani T, Poupon RE, Balkau BJ et al. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology 1990; 12: 1413-19.
37. 37 Fardy JM, Laupacis A. A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am. J. Gastroenterol. 1994; 89: 1938-48.
38. 38 Snady H, Feinman L, Lieber CS. Evaluation of propranolol and sclerotherapy, alone and in combination, for the prophylactic treatment of esophageal varices. Am. J. Gastroenterol. 1988; 83: 1065 (Abstract).
39. 39 Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 8: 800-9.
40. 40 Strauss E, Tramonte R, Silva EPS et al. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology 1992; 39: 542-5.
41. 41 Terblanche J, Bronman PC, Kahn D et al. Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five year prospective controlled clinical trial. Lancet 1983; ii: 1328-32.
42. 42 Korula R, Ralls T. The effects of chronic endoscopic variceal sclerotherapy on portal pressure in cirrhotics. Gastroenterology 1991; 101: 800-5.
43. 43 Pinto HC, Abrantes A, Esteves AV, Almeida H, Correia JP. Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am. J. Gastroenterol. 1989; 84: 1239-43.
44. 44 Westaby D, Williams R. Elective sclerotherapy: Technique and results. Endoscopy 1986; 18 (Suppl. 2): 28-31.
45. 45 Ho H, Zuckerman MJ, Wassen C. A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices. Gastroenterology 1991; 101: 1642-8.
46. 46 Schuman BM, Beckman JW, Tedesco FJ, Griffin Jr JW, Assad RT. Complications of endoscopic injection sclerotherapy: A review. Am J. Gastroenterol. 1987; 82: 823-9.
47. 47 Macdougall BRD, Westaby D, Theodossi A, Dawson JL, Williams R. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet 1982; i: 124-7.
48. 48 Takase Y, Shibuya S, Chikamori F, Orii K, Iwasaki Y. Recurrence factors studied by percutaneous transhepatic portography before and after endoscopic sclerotherapy for esophageal varices. Hepatology 1990; 11: 348-50.